Size controlled protein nanoemulsions for active targeting of folate receptor positive cells

Colloids and Surfaces B: Biointerfaces - Tập 135 - Trang 90-98 - 2015
Ana Loureiro1,2, Eugénia Nogueira1,2, Nuno G. Azoia1, Marisa P. Sárria1,2, Ana S. Abreu1, Ulyana Shimanovich3, Alexandra Rollett4, Johan Härmark5, Hans Hebert5, Georg Guebitz4,6, Gonçalo J.L. Bernardes3,7, Ana Preto2, Andreia C. Gomes2, Artur Cavaco-Paulo1
1CEB – Centre of Biological Engineering, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal
2CBMA (Centre of Molecular and Environmental Biology), Department of Biology, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal
3Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, United Kingdom
4University of Natural Resources and Life Sciences, Institute for Environmental Biotechnology, IFA Tulln, Konrad Lorenz Straße 20, 3430 Tulln, Vienna, Austria
5Department of Biosciences and Nutrition, The Royal Institute of Technology, School of Technology and Health, Karolinska Institutet, Stockholm, Sweden
6Austrian Centre of Industrial Biotechnology, Petersgasse 14, 8010 Graz, Austria
7Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal

Tài liệu tham khảo

Cho, 2008, Therapeutic nanoparticles for drug delivery in cancer, Clin. Cancer Res., 14, 1310, 10.1158/1078-0432.CCR-07-1441 Langer, 2003, Optimization of the preparation process for human serum albumin (HSA) nanoparticles, Int. J. Pharm., 257, 169, 10.1016/S0378-5173(03)00134-0 Suri, 2007, Nanotechnology-based drug delivery systems, J. Occup. Med. Toxicol., 2, 16, 10.1186/1745-6673-2-16 Elzoghby, 2012, Albumin-based nanoparticles as potential controlled release drug delivery systems, J. Controlled Release, 157, 168, 10.1016/j.jconrel.2011.07.031 Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nature Nanotechnol., 2, 751, 10.1038/nnano.2007.387 Shimanovich, 2014, Protein micro- and nano-capsules for biomedical applications, Chem. Soc. Rev., 43, 1361, 10.1039/C3CS60376H Anton, 2008, Design and production of nanoparticles formulated from nano-emulsion templates—a review, J. Controlled Release, 128, 185, 10.1016/j.jconrel.2008.02.007 Patil, 2003, Biopolymer albumin for diagnosis and in drug delivery, Drug Dev. Res., 58, 219, 10.1002/ddr.10157 Suslick, 1990, Protein microencapsulation of nonaqueous liquids, J. Am. Chem. Soc., 112, 7807, 10.1021/ja00177a058 Silva, 2012, Insights on the mechanism of formation of protein microspheres in a biphasic system, Mol. Pharm., 9, 3079, 10.1021/mp3001827 Armbruster, 2008, Limit of blank, limit of detection and limit of quantitation, Clin. Biochem. Rev., 29, S49 Pronk, 2013, GROMACS 4. 5: a high-throughput and highly parallel open source molecular simulation toolkit, Bioinformatics, 29, 845, 10.1093/bioinformatics/btt055 Lee, 2009, A coarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics, J. Phys. Chem. B, 113, 13186, 10.1021/jp9058966 Marrink, 2007, The MARTINI force field: coarse grained model for biomolecular simulations, J. Phys. Chem. B, 111, 7812, 10.1021/jp071097f Monticelli, 2008, The MARTINI coarse-grained force field: extension to proteins, J. Chem. Theory Comput., 4, 819, 10.1021/ct700324x Hess, 1997, LINCS: a linear constraint solver for molecular simulations, J. Comput. Chem., 18, 1463, 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H Berendsen, 1984, Molecular dynamics with coupling to an external bath, J. Chem. Phys., 81, 3684, 10.1063/1.448118 Neises, 1978, Simple method for the esterification of carboxylic acids, Angew. Chem. Int. Ed. Engl., 17, 522, 10.1002/anie.197805221 Jiang, 2009, Cell line cross-contamination: KB is not an oral squamous cell carcinoma cell line, Eur. J. Oral Sci., 117, 90, 10.1111/j.1600-0722.2008.00599.x Schultz, 2004, High-pressure homogenization as a process for emulsion formation, Chem. Eng. Technol., 27, 361, 10.1002/ceat.200406111 Lamprecht, 1999, Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification, Int. J. Pharm., 184, 97, 10.1016/S0378-5173(99)00107-6 Lee, 2002, Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer, J. Controlled Release, 84, 115, 10.1016/S0168-3659(02)00239-0 Ambrus, 2009, Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam, Int. J. Pharm., 381, 153, 10.1016/j.ijpharm.2009.07.009 Lamprecht, 2000, Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique, Int. J. Pharm., 196, 177, 10.1016/S0378-5173(99)00422-6 Pinto Reis, 2006, Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles, Nanomedicine, 2, 8, 10.1016/j.nano.2005.12.003 Gonçalves, 2014, Sonochemical and hydrodynamic cavitation reactors for laccase/hydrogen peroxide cotton bleaching, Ultrason. Sonochem., 21, 774, 10.1016/j.ultsonch.2013.08.006 Nogueira, 2013, Liposome and protein based stealth nanoparticles, Faraday Discuss., 166, 417, 10.1039/c3fd00057e Rohiwal, 2015, Preparation and evaluation of bovine serum albumin nanoparticles for ex vivo colloidal stability in biological media, Colloids Surf. A Physicochem. Eng. Aspects, 480, 28, 10.1016/j.colsurfa.2015.04.017 Moghimi, 1993, Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum, Biochim. Biophys. Acta, 1179, 157, 10.1016/0167-4889(93)90137-E Moghimi, 2001, Long-circulating and target-specific nanoparticles: theory to practice, Pharmacol. Rev., 53, 283 Dunn, 1997, In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers, J. Controlled Release, 44, 65, 10.1016/S0168-3659(96)01504-0 Gref, 1995, The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres, Adv. Drug Delivery Rev., 16, 215, 10.1016/0169-409X(95)00026-4 Fernández-Urrusuno, 1995, Influence of surface properties on the inflammatory response to polymeric nanoparticles, Pharm. Res., 12, 1385, 10.1023/A:1016246312350 Zahr, 2006, Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol), Langmuir, 22, 8178, 10.1021/la060951b Mosqueira, 1999, Interactions between a macrophage cell line (J774A1) and surface-modified poly(d,l-lactide) nanocapsules bearing poly(ethylene glycol), J. Drug Target., 7, 65, 10.3109/10611869909085493 Owens, 2006, Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles, Int. J. Pharm., 307, 93, 10.1016/j.ijpharm.2005.10.010 Humphrey, 1996, VMD: visual molecular dynamics, J. Mol. Graphics, 14, 33, 10.1016/0263-7855(96)00018-5 Morachis, 2012, Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles, Pharmacol. Rev., 64, 505, 10.1124/pr.111.005363 Salmaso, 2013, Stealth properties to improve therapeutic efficacy of drug nanocarriers, J. Drug Delivery, 2013, 19, 10.1155/2013/374252 Reddy, 2007, Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate, Cancer Res., 67, 6376, 10.1158/0008-5472.CAN-06-3894 Tang, 2014, Folate/NIR 797-conjugated albumin magnetic nanospheres: synthesis, characterisation, and in vitro and in vivo targeting evaluation, PLoS One, 9, e106483, 10.1371/journal.pone.0106483 Panwar, 2004, 99mTc-Tetraethylenepentamine-folate a new 99mTc based folate derivative for the detection of folate receptor positive tumors: synthesis and biological evaluation, Cancer Biol. Ther., 3, 995, 10.4161/cbt.3.10.1138 Colacino, 2014, Folate conjugated cellulose nanocrystals potentiate irreversible electroporation-induced cytotoxicity for the selective treatment of cancer cells, Technol. Cancer Res. Treat. Weitman, 1992, Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues, Cancer Res., 52, 3396 Roger, 2012, Folic acid-functionalized nanoparticles for enhanced oral drug delivery, Mol. Pharm., 9, 2103, 10.1021/mp2005388